Patents Assigned to Pfizer
-
Patent number: 4727159Abstract: Antifungal 1-[3-(substituted)-2-hydroxy-2-(perfluoroalkyl)-propyl]triazole derivatives wherein the 3-propyl substituent represents optionally substituted phenoxy, heteroaryloxy, alkylthio, alkylsulfinyl, alkylsulfonyl or optionally substituted carbamoyl.Type: GrantFiled: September 5, 1986Date of Patent: February 23, 1988Assignee: Pfizer Inc.Inventors: Kenneth Richardson, Peter J. Whittle
-
Patent number: 4725599Abstract: Certain trans-3-[3-(3-hydroxy-2-piperidyl)-2-oxopropyl]thieno[3,2-d]pyrimidin-4(3H )-one and furo[3,2-d]pyrimidin-4(3H)-one derivatives, a method of using same as anticoccidial agents, intermediates therefor, and a process for certain intermediates therefor.Type: GrantFiled: September 8, 1986Date of Patent: February 16, 1988Assignee: Pfizer Inc.Inventors: Edward A. Glazer, James W. McFarland
-
Patent number: 4725616Abstract: 1,3-Dicarboxamidooxindoles as antiinflammatory agents prepared by reaction of the 1-carbamoyloxindole with an isocyanate or by aminolysis of the corresponding alkyl 1-carbamoyloxindole-3-carboxylate.Type: GrantFiled: January 20, 1987Date of Patent: February 16, 1988Assignee: Pfizer Inc.Inventor: Saul B. Kadin
-
Patent number: 4725678Abstract: Certain 2-substituted-2-penem-3-carboxylic acid compounds and pharmaceutically-acceptable salts thereof can be prepared from the appropriate xanthate or trithiocarbonate by desulfurization and addition of an electrophilic sulfur compound followed by halogenation and ring closure. The corresponding desulfurized and halogenated olefinic intermediates are disclosed.Type: GrantFiled: April 4, 1986Date of Patent: February 16, 1988Assignee: Pfizer Inc.Inventor: Ernest S. Hamanaka
-
Patent number: 4723010Abstract: Chloromethyl group substituted heterocyclic compounds of the formulae ##STR1## wherein X is O or S;Y together with the two carbons to which Y is attached forms phenyl, pyridyl or pyrimidyl, each of which may be substituted by R;R is one of iodo or trifluoromethylthio or one or two of fluoro, chloro, bromo, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy, (C.sub.1 -C.sub.4)alkylthio, (C.sub.1 -C.sub.4)alkylsulfinyl, (C.sub.1 -C.sub.4)alkylsulfonyl or trifluoromethyl; andR.sup.1 is hydrogen or R, are prepared by reacting a bifunctional compound of the formulae ##STR2## with a 2-chloro-1,1,1-tri(C.sub.1 -C.sub.6)alkoxyethane. Most of the compounds of formulae I and II are novel. These compounds are intermediates of use in the preparation of compounds having pharmaceutical activity. The 2-chloro-1,1,1-tri(C.sub.1 -C.sub.6)alkoxyethanes are prepared from the corresponding tri(C.sub.1 -C.sub.6)alkoxyethanes by chlorination with N-chlorosuccinimide or with chlorine in pyridine and a chlorohydrocarbon cosolvent.Type: GrantFiled: November 7, 1985Date of Patent: February 2, 1988Assignee: Pfizer Inc.Inventors: Banavara L. Mylari, William J. Zembrowski
-
Patent number: 4721712Abstract: Certain 2-oxindole-1-carboxamide compounds having an acyl substituent at the 3-position, and also on the carboxamide nitrogen atom, are inhibitors of the cyclooxygenase (CO) and lipoxygenase (LO) enzymes, and are useful as analgesic agents and anti-inflammatory agents in mammalian subjects. These 2-oxindole-1-carboxamide compounds are of particular value for acute administration for ameliorating pain in human patients recovering from surgery or trauma, and also for chronic administration to human subjects for alleviating the symptoms of chronic diseases, such as rheumatoid arthritis and osteoarthritis. Certain 2-oxindole-1-carboxamide compounds unsubstituted at C-3, but having an acyl substituent on the carboxamide nitrogen atom, are useful as intermediates to the aforementioned analgesic and anti-inflammatory agents.Type: GrantFiled: November 13, 1984Date of Patent: January 26, 1988Assignee: Pfizer Inc.Inventor: Saul B. Kadin
-
Patent number: 4718911Abstract: A three-component acetabular cup assembly for receiving and releasably retaining the femoral head component of a prosthesis, said cup assembly comprising an outer metal shell, a cup-shaped inner bearing of substantially rigid plastic fixedly secured within said metal shell, and a locking ring made from the same plastic as the inner bearing; the outer surface of the bearing and the inner surface of the locking ring having cooperating configurations forming a secure but releasable latch.Type: GrantFiled: February 19, 1986Date of Patent: January 12, 1988Assignee: Pfizer Hospital Products Group Inc.Inventor: Robert V. Kenna
-
Patent number: 4716900Abstract: An improved intraintestinal bypass graft for attachment in the lumen of a resectioned intestine or duct upstream of the anastomosis site in order to protect the healing anastomosis comprises an elongated tube formed of a thin, highly flexible, water-impervious wall material terminating at its distal end in a short, reduced diameter nipple. The surgical procedure for implanting the bypass graft can be simplified and shortened in time by readily fitting the distal nipple over one end of an elongated pliable leader, or alternatively over the terminal anvil nut of a circular anastomosis surgical stapler, and then drawing the leader or stapler body through the patient's anus to pull the distal end of the bypass graft out of the anus. The need to tie the distal end of the bypass graft to the leader or surgical stapler is eliminated.Type: GrantFiled: May 9, 1986Date of Patent: January 5, 1988Assignee: Pfizer Hospital Products Group, Inc.Inventors: Biagio Ravo, Thomas E. Sloane, Jr., Christine L. Regan
-
Patent number: 4716113Abstract: An improved process for preparing (4S)-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione (sorbinil) or its (2R)-methyl derivative (2-methylsorbinil) is disclosed herein, starting from p-fluorophenol in each instance. The final products obtained have known pharmaceutical value as agents for the control of certain chronic diabetic complications. Key steps concerned with the process involve converting p-fluorophenol into the appropriate .beta.-(4-fluorophenoxy)alkane halide, followed by amidoalkylation with N-benzoyl or N-(lower alkanoyl)-.alpha.-hydroxyglycine to form an intermediate 2-amidoalkylated derivative thereof, and then dehydration and spiroalkylation of said intermediate by treatment with a dehydrating agent and a base to yield a spiroalkylated azlactone compound.Type: GrantFiled: March 31, 1986Date of Patent: December 29, 1987Assignee: Pfizer Inc.Inventor: Frank J. Urban
-
Patent number: 4716231Abstract: A novel process for chlorinating 2-methoxynicotinic acid at the 5-position of the molecule is disclosed. The process involves the use of an alkali metal hypochlorite as the chlorinating agent in a homogeneous aqueous solvent system. The compound so produced, 5-chloro-2-methoxynicotinic acid, is known to be useful as an intermediate leading to various oral hypoglycemic agents of the benzenesulfonylurea class.Type: GrantFiled: April 27, 1987Date of Patent: December 29, 1987Assignee: Pfizer Inc.Inventor: Carl J. Goddard
-
Patent number: 4715855Abstract: A fluid drainage system includes a suction chamber and a collection chamber. The suction chamber includes a suction regulator comprised of first and second chambers separated by a divider. An opening in the divider has a biased closing member associated therewith for opening or closing the opening according to the pressure differential between the chambers. A dash pot is connected to the closing member for damping the force on the closing member. The drainage system further includes devices for measuring the patient airflow, patient negativity and imposed suction. Those devices consist of diaphragms having dials connected thereto such that movement of the diaphragm results in movement of the dial and thereby indicating a change in one of the above noted variables. As an alternative, the drainage system includes a venturi meter for measuring airflow. Finally, the system contains an anti-spill device that prevents the spilling of fluids from the collection chamber to other chambers in the device.Type: GrantFiled: August 20, 1984Date of Patent: December 29, 1987Assignee: Pfizer Hospital Products Group, Inc.Inventors: Nicholas F. D'Antonio, Nicholas J. D'Antonio
-
Patent number: 4714761Abstract: A process for the preparation of penicillanic acid 1,1-dioxide and esters thereof readily hydrolyzable in vivo, which comprises oxidation of a 6,6-dihalopenicillanic acid, or an ester thereof readily hydrolyzable in vivo, to the corresponding 6,6-dihalopenicillanic acid 1,1-dioxide or ester thereof, followed by dehalogenation (e.g. by hydrogenolysis). The 6,6-dihalopenicillanic acid 1,1-dioxides and esters thereof readily hydrolyzable in vivo are novel intermediates. Penicillanic acid 1,1-dioxide, and esters thereof readily hydrolyzable in vivo, are known compounds which are useful as beta-lactamase inhibitors and for enhancing the effectiveness of certain beta-lactam antibiotics (e.g. the penicillins) in the treatment of bacterial infections in mammals, particularly humans.Type: GrantFiled: July 25, 1986Date of Patent: December 22, 1987Assignee: Pfizer Inc.Inventors: Ronnie D. Carroll, Robert A. Volkmann
-
Patent number: 4714603Abstract: A precipitated calcite of substantially spherical morphology having an average spherical diameter of from 2 to 10 microns and a specific surface area of from 1 to 15 square meters per gram is prepared by introducing carbon dioxide gas into an aqueous slurry of calcium hydroxide containing dissolved polyphosphate in the amount of from 0.1 to 1.0 percent, calculated as grams of phosphorus per 100 grams of the calcite equivalent of the calcium hydroxide, the starting temperature of the carbonation being 15.degree. to 50.degree. C. The spherical calcite is particularly suitable for use in dull finish coated paper.Type: GrantFiled: May 8, 1986Date of Patent: December 22, 1987Assignee: Pfizer, Inc.Inventor: Dennis B. Vanderheiden
-
Patent number: 4714468Abstract: A dispersion strengthened cobalt-chromium-molybdenum alloy produced by gas atomization containing a fine oxide dispersion, and characterized, after fabrication by gas atomization, thermomechanical processing and further high temperature exposure, by excellent corrosion resistance, high fatigue strength, high ductility and high temperature stability; a process for producing said alloy and prostheses formed from said alloy.Type: GrantFiled: January 27, 1987Date of Patent: December 22, 1987Assignee: Pfizer Hospital Products Group Inc.Inventors: Kathy K. Wang, Larry J. Gustavson, John H. Dumbleton
-
Patent number: 4714469Abstract: A spinal implant adapted to replace a disc between adjacent vertebrae having a predetermined thickness and profile chosen to match the space between said vertebrae and characterized by elongated protuberances adapted to be located in grooves drilled in said vertebrae and a porous coating on at least a portion of its surface. A method and apparatus for placement of said spinal implant are also disclosed.Type: GrantFiled: February 26, 1987Date of Patent: December 22, 1987Assignee: Pfizer Hospital Products Group, Inc.Inventor: Robert V. Kenna
-
Patent number: 4711882Abstract: A series of novel octahydro-6-azaindole dipeptide derivatives have been prepared, including their pharmaceutically acceptable salts and bioprecursors therefor. These particular compounds are inhibitors of the angiotensin converting enzyme and are therefore useful in therapy for the treatment of certain cardiovascular disorders, including heart failure and hypertension. Preferred member compounds include 1-[N-(1-S-ethoxycarbonyl-3-phenylpropyl)-S-alanyl]-2-S-carboxy-6-(N-methyl carbamoyl)-octahydro-6-azaindole, 1-[N-(1-S-ethoxycarbonyl-3-phenylpropyl-S-alanyl]-2-S-carboxy-6-methanesul phonyl-octahydro-6-azaindole and 1-[N-(1-carboxy-3-phenylpropyl)-S-lysyl]-2-carboxy-6-methanesulphonyl-octa hydro-6-azaindole, respectively. Methods for preparing these compounds from known starting materials are provided.Type: GrantFiled: December 19, 1985Date of Patent: December 8, 1987Assignee: Pfizer Inc.Inventors: Simon F. Campbell, Ryszard J. Kobylecki
-
Patent number: 4711888Abstract: 2-Amino-4-substituted-5-(hydroxy or alkoxy)pyrimidines, which may be 6-substituted, and derivatives thereof are inhibitors of leukotriene synthesis and are therefore useful for the treatment of pulmonary, inflammatory, allergic and cardiovascular diseases. The compounds are also cytoprotective and therefore useful in the treatment of peptic ulcers.Type: GrantFiled: July 24, 1985Date of Patent: December 8, 1987Assignee: Pfizer Inc.Inventors: Frederick J. Walker, John L. LaMattina
-
Patent number: 4710537Abstract: Substantially homogeneous acrylate/maleate copolymers of number average molecular weight of 500 to 5000 are prepared by copolymerizing 35 to 65 mole percent acrylic or methacrylic acid with 65 to 35 mole percent maleic anhydride at 80.degree. to 150.degree. C. in the presence of a polymerization initiator and a chain-transfer solvent such that both the monomers and the formed polymer remain in solution and the mole ratio of the acrylic or methacrylic acid monomer to the maleic anhydride monomer in the solvent is maintained below about 0.2 throughout the polymerization. The copolymers in hydrolyzed form are employed at a level of from about 0.1 to 100 ppm for prevention of alkaline calcium and magnesium scale formation, such as during seawater evaporative desalination.Type: GrantFiled: October 11, 1985Date of Patent: December 1, 1987Assignee: Pfizer Inc.Inventor: Stanley W. Walinsky
-
Patent number: 4710507Abstract: A heterocyclic-substituted 2-quinolone compound of the formula: ##STR1## or a pharmaceutically-acceptable salt thereof, wherein "Het" is an optionally substituted 5-or 6-membered monocyclid aromatic heterocyclic group attached by a carbon atom to the 5-, 6-, 7- or 8- position of the quinolone nucleus; R, which is attached to the 5-, 6-, 7- or 8- position, is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkylthio, C.sub.1 -C.sub.4 alkylsulphinyl, C.sub.1 -C.sub.4 alkylsulphonyl, halo, CF.sub.3, hydroxy, hydroxymethyl, or cyano; R.sup.1 is hydrogen, cyano (C.sub.1 -C.sub.4 alkoxy)carbonyl, C.sub.1 -C.sub.4 alkyl, nitro, halo, --NR.sup.3 R.sup.4 or --CONR.sup.3 R.sup.4 where each of R.sup.3 and R.sup.4 is hydrogen or C.sub.1 -C.sub.4 alkyl or R.sup.3 and R.sup.4 together with the nitrogen atom to which they are attached form a saturated 5- or 6-membered heterocyclic group optionally containing a further heteroatom or group selected from O, S and N--R.sup.5 where R.sup.Type: GrantFiled: December 18, 1984Date of Patent: December 1, 1987Assignee: Pfizer Inc.Inventors: Simon F. Campbell, David A. Roberts
-
Patent number: 4708132Abstract: A device for affixing a pretensioned ligament or tendon prosthesis to a bone of a patient includes a hollow elongated sleeve adapted to fit within a through drill hole in the bone and a cooperating wedge. A portion of the bore of the hollow sleeve is tapered with decreasing bore cross-sectional thickness towards the front end of the elongated sleeve. Th wedge is shaped so that a portion of a ligament or tendon prosthesis can be securely trapped between the wedge and the inner wall of the sleeve when the wedge is fully advanced forwardly within the sleeve. The device also includes a locking nut or ferrule for releasably locking the sleeve and wedge together with the wedge fully advanced within the sleeve, and a releasable bolt/washer assembly for preventing the prosthesis from being pulled forwardly through the drill hole in the patient's bone. The device is easy to use and provides a highly secure fixation of the pretensioned prosthesis.Type: GrantFiled: January 24, 1986Date of Patent: November 24, 1987Assignee: Pfizer-Hospital Products Group, Inc.Inventor: Thomas A. Silvestrini